Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6790505rdf:typepubmed:Citationlld:pubmed
pubmed-article:6790505lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6790505lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:6790505lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:6790505lifeskim:mentionsumls-concept:C0011880lld:lifeskim
pubmed-article:6790505lifeskim:mentionsumls-concept:C0442117lld:lifeskim
pubmed-article:6790505pubmed:issue6lld:pubmed
pubmed-article:6790505pubmed:dateCreated1981-10-25lld:pubmed
pubmed-article:6790505pubmed:abstractTextSeven dogs with diabetic ketoacidosis were treated initially with lactated Ringer's solution or 0.45% NaCl solution subcutaneously or intravenously and low doses of regular (crystalline) insulin administered intramuscularly every hour until the blood glucose concentration decreased to less than 250 mg/dl. For dogs weighing less than or equal to 10 kg, the initial dose was 2 units and the hourly doses were 1 unit. For dogs weighing greater than 10 kg, the initial dosage was 0.25 units/kg of body weight, and the dosage for hourly injections was 0.1 units/kg. The mean hourly decrease of the blood glucose concentration for all 7 dogs was 87.6 mg/dl. The mean period of treatment required was 4.1 hours. Late hypoglycemia did not develop in any dog, but the serum potassium concentration decreased 0.4 to 1.0 mEq/L. The results suggested that low-dose intramuscular regular insulin therapy for treatment of diabetic ketoacidosis is an effective alternative to conventional regular insulin therapy in dogs.lld:pubmed
pubmed-article:6790505pubmed:languageenglld:pubmed
pubmed-article:6790505pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6790505pubmed:citationSubsetIMlld:pubmed
pubmed-article:6790505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6790505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6790505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6790505pubmed:statusMEDLINElld:pubmed
pubmed-article:6790505pubmed:monthMarlld:pubmed
pubmed-article:6790505pubmed:issn0003-1488lld:pubmed
pubmed-article:6790505pubmed:authorpubmed-author:ChastainC BCBlld:pubmed
pubmed-article:6790505pubmed:authorpubmed-author:NicholsC ECElld:pubmed
pubmed-article:6790505pubmed:issnTypePrintlld:pubmed
pubmed-article:6790505pubmed:day15lld:pubmed
pubmed-article:6790505pubmed:volume178lld:pubmed
pubmed-article:6790505pubmed:ownerNLMlld:pubmed
pubmed-article:6790505pubmed:authorsCompleteYlld:pubmed
pubmed-article:6790505pubmed:pagination561-4lld:pubmed
pubmed-article:6790505pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:meshHeadingpubmed-meshheading:6790505-...lld:pubmed
pubmed-article:6790505pubmed:year1981lld:pubmed
pubmed-article:6790505pubmed:articleTitleLow-dose intramuscular insulin therapy for diabetic ketoacidosis in dogs.lld:pubmed
pubmed-article:6790505pubmed:publicationTypeJournal Articlelld:pubmed